Prairie Pharms Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • (Cancelled)
  • Latest Deal Amount
  • $12M
Latest Deal Amount

Prairie Pharms General Information


Developer of small molecule plant extracts that contains Thymoquinone. The company's product used to create pharmaceutical grade, lipid soluble and cell permeable human health products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Commercial Products
Primary Office
  • 3261 Cameo Avenue
  • Nora Springs, IA 50458
  • United States
+1 (641) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prairie Pharms Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 14-Apr-2016 $12M Cancelled Generating Revenue
1. Angel (individual) 29-May-2013 00000 00000 Completed Startup
To view Prairie Pharms’s complete valuation and funding history, request access »

Prairie Pharms Executive Team (2)

Name Title Board Seat Contact Info
William Rohlfsen Manager & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Prairie Pharms Board Members (4)

Name Representing Role Since
John Relher Prairie Pharms Board Member 000 0000
Joseph Saluri Prairie Pharms Board Member 000 0000
Nicholas Rohlfsen Prairie Pharms Board Member 000 0000
William Rohlfsen Prairie Pharms Manager & Board Member 000 0000
To view Prairie Pharms’s complete board members history, request access »